| abstract |
The present invention relates to a novel peptide having better activity on glucagon-like peptide-1 receptor and glucagon receptor than natural oxytonin, and a novel peptide containing the peptide as an active ingredient for preventing or treating obesity.组合 物。 Composition. Unlike natural antacids, the novel peptides of the present invention reduce food intake, inhibit gastric emptying and promote lipolysis, have reduced side effects, and also exhibit excellent receptor activation effects. Therefore, it has a wide range of safety and efficacy in the treatment of obesity. |